News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
179,556 Results
Type
Article (7290)
Company Profile (62)
Press Release (172203)
Multimedia
Podcasts (4)
Webinars (1)
Section
Business (53696)
Career Advice (212)
Deals (9070)
Drug Delivery (10)
Drug Development (24642)
Employer Resources (22)
FDA (4236)
Job Trends (4200)
News (89568)
Policy (7317)
Tag
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
Academia (512)
Accelerated approval (14)
Adcomms (2)
Allergies (69)
Alliances (7581)
ALS (89)
Alzheimer's disease (692)
Antibody-drug conjugate (ADC) (168)
Approvals (4613)
Artificial intelligence (259)
Autoimmune disease (110)
Automation (25)
Bankruptcy (48)
Best Places to Work (3962)
BIOSECURE Act (4)
Biosimilars (89)
Biotechnology (32)
Bladder cancer (127)
Brain cancer (24)
Breast cancer (379)
Cancer (2629)
Cardiovascular disease (214)
Career advice (193)
Career pathing (10)
CAR-T (94)
CDC (8)
Cell therapy (271)
Cervical cancer (23)
Clinical research (23612)
Collaboration (812)
Company closure (2)
Compensation (503)
Complete response letters (17)
COVID-19 (943)
CRISPR (44)
C-suite (357)
Cystic fibrosis (65)
Data (3717)
Depression (53)
Diabetes (222)
Diagnostics (1992)
Digital health (23)
Diversity (2)
Diversity, equity & inclusion (5)
Drug discovery (112)
Drug pricing (27)
Drug shortages (4)
Duchenne muscular dystrophy (125)
Earnings (41991)
Editorial (10)
Employer branding (2)
Employer resources (23)
Events (29277)
Executive appointments (436)
FDA (5982)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (3)
Frontotemporal dementia (14)
Funding (675)
Gene editing (85)
Generative AI (13)
Gene therapy (239)
GLP-1 (366)
Government (1317)
Grass and pollen (3)
Guidances (333)
Healthcare (5738)
HIV (48)
Huntington's disease (27)
IgA nephropathy (52)
Immunology and inflammation (84)
Immuno-oncology (25)
Indications (76)
Infectious disease (1076)
Inflammatory bowel disease (72)
Inflation Reduction Act (2)
Influenza (48)
Intellectual property (78)
Interviews (40)
IPO (5766)
IRA (3)
Job creations (539)
Job search strategy (152)
JPM (6)
Kidney cancer (10)
Labor market (28)
Layoffs (107)
Leadership (4)
Legal (1193)
Liver cancer (37)
Longevity (9)
Lung cancer (385)
Lymphoma (242)
Machine learning (26)
Management (7)
Manufacturing (312)
MASH (105)
Medical device (3990)
Medtech (4020)
Mergers & acquisitions (3824)
Metabolic disorders (569)
mRNA (28)
Multiple sclerosis (97)
NASH (10)
Neurodegenerative disease (160)
Neuropsychiatric disorders (31)
Neuroscience (1263)
NextGen: Class of 2026 (1265)
Non-profit (1066)
Now hiring (6)
Obesity (229)
Opinion (21)
Ovarian cancer (78)
Pain (75)
Pancreatic cancer (103)
Parkinson's disease (136)
Partnered (6)
Patents (141)
Patient recruitment (237)
Peanut (30)
People (8472)
Pharmaceutical (14)
Pharmacy benefit managers (7)
Phase 1 (6184)
Phase 2 (10034)
Phase 3 (9296)
Pipeline (3925)
Policy (24)
Postmarket research (862)
Preclinical (1995)
Press Release (16)
Prostate cancer (154)
Psychedelics (4)
Radiopharmaceuticals (84)
Rare diseases (384)
Real estate (892)
Recruiting (14)
Regulatory (6662)
Reports (20)
Research institute (531)
Resumes & cover letters (18)
Rett syndrome (24)
RNA editing (4)
RSV (49)
Schizophrenia (62)
Series A (105)
Series B (82)
Sickle cell disease (44)
Special edition (12)
Spinal muscular atrophy (64)
Sponsored (8)
Startups (482)
Stomach cancer (3)
Supply chain (40)
Tariffs (12)
The Weekly (4)
Vaccines (375)
Venture capital (22)
Weight loss (149)
Women's health (46)
Worklife (6)
Date
Today (64)
Last 7 days (309)
Last 30 days (1550)
Last 365 days (14762)
2026 (3236)
2025 (14992)
2024 (12050)
2023 (10779)
2022 (22611)
2021 (20163)
2020 (12692)
2019 (10291)
2018 (7758)
2017 (7126)
2016 (5759)
2015 (7553)
2014 (5327)
2013 (3782)
2012 (4524)
2011 (4663)
2010 (4260)
Location
Africa (134)
Alabama (23)
Alaska (2)
Arizona (64)
Arkansas (5)
Asia (10684)
Australia (1447)
California (5859)
Canada (1377)
China (448)
Colorado (231)
Connecticut (321)
Delaware (236)
Europe (25167)
Florida (623)
Georgia (150)
Hawaii (4)
Idaho (14)
Illinois (481)
India (33)
Indiana (240)
Iowa (9)
Japan (319)
Kansas (24)
Kentucky (17)
Louisiana (22)
Maine (33)
Maryland (682)
Massachusetts (4215)
Michigan (112)
Minnesota (330)
Mississippi (3)
Missouri (63)
Montana (7)
Nebraska (3)
Nevada (70)
New Hampshire (25)
New Jersey (1674)
New Mexico (7)
New York (1421)
North Carolina (579)
North Dakota (1)
Northern California (2911)
Ohio (141)
Oklahoma (5)
Oregon (15)
Pennsylvania (956)
Puerto Rico (10)
Rhode Island (16)
South America (192)
South Carolina (10)
Southern California (2248)
Tennessee (83)
Texas (863)
United States (19815)
Utah (118)
Virginia (146)
Washington D.C. (27)
Washington State (469)
West Virginia (2)
Wisconsin (95)
Wyoming (1)
179,556 Results for "24".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioCardia to Host 2025 Financial Results and Corporate Update Conference Call on March 24, 2026
March 20, 2026
·
2 min read
Press Releases
Bausch + Lomb Announces Positive 24-Month U.S. Data on the ELIOS™ System for Treatment of Glaucoma
March 23, 2026
·
5 min read
Press Releases
Cytokinetics to Announce Fourth Quarter Results on February 24, 2026
February 12, 2026
·
3 min read
Press Releases
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2025 Financial Results on March 24, 2026
March 18, 2026
·
2 min read
Press Releases
Capital Increase in Genmab as a Result of Employee Warrant Exercise - February 24, 2026
February 25, 2026
·
3 min read
Press Releases
BioHarvest Sciences to Participate in 38th Annual Roth Conference on March 22-24, 2026
March 3, 2026
·
1 min read
Press Releases
MaxCyte to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026
February 24, 2026
·
1 min read
Press Releases
Fractyl Health to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Updates on March 24, 2026
March 17, 2026
·
1 min read
Press Releases
LENZ Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights on March 24, 2026
March 17, 2026
·
1 min read
Press Releases
BioStem Technologies to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 24, 2026
March 12, 2026
·
1 min read
1 of 17,956
Next
